Results 101 to 110 of about 2,540 (169)

RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. [PDF]

Research (Wash D C)
Ali I, Qiu J, Cheang WS, Wang G, Xu S.
europepmc   +1 more source

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]

Cureus
Khan JA, Shahab S.
europepmc   +1 more source

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors. [PDF]

J Clin Med Res
Patel J, Shah S, Reddy A, Prajapati D, Pandya A, Sawhney S.   +5 more
europepmc   +1 more source

Association between inclisiran and the risk of arrhythmias

IJC Heart & Vasculature
Vikash Jaiswal, Fakhar Latif, Zarghoona Wajid, Nishat Shama, Anupam Halder, Dhrubajyoti Bandyopadhyay, Jishanth Mattumpuram, Monodeep Biswas   +7 more
openaire   +3 more sources

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis.

JAMA Netw Open
Kellogg C, Badillo Goicoechea E, Kim DD, Yaghi S, Chaturvedi S, Mehendale R, Orjuela K, Kass-Hout T, Morsi RZ, Morales J, Singh E, Jhaveri A, Prabhakaran S, Smith MM, Brorson JR, Golani S, Mazuera S, Kang R, Eltatawy A, Pillajo J, Siegler JE.   +20 more
europepmc   +1 more source

RNA therapeutics: A promising therapy for future cardiology. [PDF]

J Cardiovasc Thorac Res
Ghaffari S, Entezari-Maleki T.
europepmc   +1 more source

Clinical and genetic characterization of homozygous <i>LDLR</i> variants in familial hypercholesterolaemia: insights from two case reports. [PDF]

Eur Heart J Case Rep
Sahoo SK, Singh PK, Barik R, Prakash S, Sahoo D, Mohanty CR, Malla SR, Mohapatra RK.   +7 more
europepmc   +1 more source

Paradoxical LDL-C Increase after Switching from PCSK9 Inhibitors to Inclisiran: A Real-World Case Series. [PDF]

Acta Cardiol Sin
Chua SK, Hung HF, Jong BH, Chen LC.
europepmc   +1 more source

Inclisiran in Chronic Kidney Disease Patients: A Real-World Experience.

Cardiorenal Med
Dello Strologo A, Franculli A, Saporito P, Miani N, Bellasi A, Lido P, Di Lullo L, Ronco C, Peverini P.   +8 more
europepmc   +1 more source